Guohong S. Zhang

Shantou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

A distinct subgroup with Schwann-like differentiation presents immune resistance and poor prognosis in plantar melanoma.

A distinct subgroup with Schwann-like differentiation presents immune resistance and poor prognosis in plantar melanoma.

Journal: Theranostics
Published: June 12, 2024

Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials.

Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials.

Journal: Oncotarget
Published: May 01, 2015

Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.

Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.

Journal: Oncotarget
Published: February 25, 2015

Stage-specific prognostic biomarkers in melanoma.

Stage-specific prognostic biomarkers in melanoma.

Journal: Oncotarget
Published: September 25, 2014

Value of C-arm computed tomography in radiofrequency ablation of small lung lesions.

Value of C-arm computed tomography in radiofrequency ablation of small lung lesions.

Journal: Genetics and molecular research : GMR
Published: August 14, 2014

Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma.

Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma.

Journal: Molecular medicine reports
Published: May 31, 2014

Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.

Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.

Journal: Oncology reports
Published: May 30, 2014

A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma.

A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma.

Journal: BMC cancer
Published: November 10, 2013

JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma.

JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma.

Journal: Carcinogenesis
Published: September 26, 2013

Targeting MAPK pathway in melanoma therapy.

Targeting MAPK pathway in melanoma therapy.

Journal: Cancer metastasis reviews
Published: April 16, 2013

C-terminal tensin-like protein is a novel prognostic marker for primary melanoma patients.

C-terminal tensin-like protein is a novel prognostic marker for primary melanoma patients.

Journal: PloS one
Published: February 28, 2013

Novel multiple markers to distinguish melanoma from dysplastic nevi.

Novel multiple markers to distinguish melanoma from dysplastic nevi.

Journal: PloS one
Published: June 11, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026